VACOP-B vs VACOP-B plus high-dose sequential therapy (RDS) for aggressive non-Hodgkin's lymphoma (NHL).

被引：0

作者：

Santini, G ^{[1
]}

Olivieri, A ^{[1
]}

Majolino, I ^{[1
]}

Chisesi, T ^{[1
]}

Salvagno, L ^{[1
]}

Biglio, A ^{[1
]}

de Souza, C ^{[1
]}

Congiu, M ^{[1
]}

Rizzoli, V ^{[1
]}

机构：

[1] Osped San Martino Genova, Dept Haematol, Genoa, Italy

来源：

BLOOD | 2001年 / 98卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3576

引用

页码：862A / 862A

页数：1

共 50 条

[1] Vacop-B vs Vacop-B plus high-dose sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma (NHL)
Santini, G
Congiu, A
Olivieri, A
Malolino, I
Chisesi, T
Salvagno, L
Quaini, R
Rubagotti, A
Centurioni, R
Contu, A
Candela, M
Rizzoli, V
BONE MARROW TRANSPLANTATION, 2002, 29 : S8 - S9
[2] Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG
Santini, G
Olivieri, A
Majolino, I
Congiu, A
Chisesi, T
De Souza, C
Patti, C
Salvagno, L
Quaini, R
Rubagotti, A
Centurioni, R
Contu, A
Candela, M
Rizzoli, V
BONE MARROW TRANSPLANTATION, 2003, 31 : S5 - S5
[3] VACOP-B versus VACOP-B plus High-Dose Sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma. Interim analysis of a randomised trial.
Santini, G
Leoni, P
Majolino, I
BONE MARROW TRANSPLANTATION, 2001, 27 : S13 - S13
[4] VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma (NHL). Results of a prospective randomised trial.
Santini, G
Salvagno, L
Leoni, P
Chisesi, T
Congiu, AM
Rizzoli, V
BLOOD, 1998, 92 (10) : 465A - 465A
[5] VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma. Results of a prospective randomised trial
Santini, G
Salvagno, L
Leoni, P
Chisesi, T
Rizzoli, V
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 152 - 152
[6] VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma. Results of a prospective randomised trial.
Santini, G
Salvagno, L
Leoni, P
Chisesi, T
Rizzoli, V
EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 746 - 746
[7] VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group
Santini, G
Salvagno, L
Leoni, P
Chisesi, T
De Souza, C
Sertoli, MR
Rubagotti, A
Congiu, AM
Centurioni, R
Olivieri, A
Tedeschi, L
Vespignani, M
Nati, S
Soracco, M
Porcellini, A
Contu, A
Guarnaccia, C
Pescosta, N
Majolino, I
Spriano, M
Vimercati, R
Rossi, E
Zambaldi, G
Mangoni, L
Endrizzi, L
Sileni, VC
Miggiano, MC
Marino, G
Damasio, E
Rizzoli, V
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2796 - 2802
[8] Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG
Olivieri, A
Santini, G
Patti, C
Chisesi, T
De Souza, C
Rubagotti, A
Aversa, S
Billio, A
Porcellini, A
Candela, M
Centurioni, R
Congiu, AM
Brunori, M
Nati, S
Spriano, M
Vimercati, R
Marino, G
Contu, A
Tedeschi, L
Majolino, I
Crugnola, M
Sertoli, MR
ANNALS OF ONCOLOGY, 2005, 16 (12) : 1941 - 1948
[9] VACOP-B for stage I/II aggressive non-Hodgkin's lymphoma: Report from the NHLCSG.
Santini, G
Salvagno, L
Majolino, I
Chisesi, T
Candela, M
Olivieri, A
Tedeschi, L
Vivaldi, P
Contu, T
Coser, P
Rizzoli, V
Rubagotti, A
Endrizzi, L
Porcellini, A
De Souza, C
BLOOD, 2000, 96 (11) : 247B - 247B
[10] Prospective randomised study comparing 12-week VACOP-B regimen versus 6-week VACOP-B plus high-dose sequential followed by autologous bone marrow transplantation in high-risk IPI aggressive non-Hodgkin lymphoma. A Brazilian GEMOH report
De Souza, CA
Cardoso, RB
Simoes, BP
Maiolino, A
Moraes, AJG
Ruiz, MA
Lorand-Metze, IGH
Vigorito, AC
Aranha, FJP
Miranda, ECM
Nucci, M
BONE MARROW TRANSPLANTATION, 2004, 33 : S349 - S349

← 1 2 3 4 5 →